Sequent Scientific allots equity shares

On preferential basis

Sequent Scientific announced that the Board of Directors of the Company on 13 August 2015 has approved the allotment of 757,734 equity shares at a price of Rs. 669.10 per equity share (including a premium of Rs. 659.10 per equity share) to Devicam Capital LLP, a promoter group entity by way of preferential issue in compliance with Chapter VII of the Securities & Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009.

Consequent to the allotment, the paid up equity share capital of the Company has increased from Rs. 412,618,260/- consisting of 41,261,826 equity shares of Rs. 10/- each to Rs. 420,195,600/- consisting of 42,019,560 equity shares of Rs. 10/- each.

 

Powered by Capital Market - Live News